科研之友
微信
新浪微博
Facebook
分享链接
摘要
Glutathione (GSH) depletion is the earliest biochemical alteration shown to date in brains of Parkinson's disease patients. However, data from animal models show that GSH depletion by itself is not sufficient to induce nigral degeneration. We have previously shown that non-toxic inhibition of GSH synthesis with L-buthionine-(S, R)sulfoximine in primary midbrain cultures transforms a nitric oxide ( NO) neurotrophic effect, selective for dopamine neurons, into a toxic effect with participation of guanylate cyclase ( GC) and cGMP-dependent protein kinase (PKG) ( Canals, S., Casarejos, M. J., de Bernardo, S., Rodriguez-Martin, E., and Mena, M. A. (2001) J. Neurochem. 79, 1183 - 1195). Here we demonstrate that arachidonic acid ( AA) metabolism through the 12-lipoxygenase (12-LOX) pathway is also central for this GSH-NO interaction. LOX inhibitors ( nordihydroguaiaretic acid and baicalein), but not cyclooxygenase ( indomethacin) or epoxygenase ( clotrimazole) ones, prevent cell death in the culture, even when added 10 h after NO treatment. Furthermore, the addition of AA to GSH-depleted cultures precipitates a cell death process that is indistinguishable from that initiated by NO in its morphology, time course, and 12-LOX, GC, and PKG dependence. The first AA metabolite through the 12-LOX enzyme, 12-hydroperoxyeicosatetraenoic acid, induces cell death in the culture, and its toxicity is greatly enhanced by GSH depletion. In addition we show that if GSH synthesis inhibition persists for up to 4 days without any additional treatment, it will induce a cell death process that also depends on 12-LOX, GC, and PKG activation. In this study, therefore, we show that the signaling pathway AA/12-LOX/12-HPETE/GC/ PKG may be important in several pathologies in which GSH decrease has been documented, such as Parkinson's disease. The potentiating effect of NO over such a signaling pathway may be of relevance as part of the cascade of events leading to and sustaining nerve cell death.
- 出版日期2003-6-13
